These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17213264)

  • 1. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
    Insa R; Cercenado E; Goyanes MJ; Morente A; Bouza E
    J Antimicrob Chemother; 2007 Mar; 59(3):583-5. PubMed ID: 17213264
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H; Stefanik D; Wisplinghoff H
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract]   [Full Text] [Related]  

  • 5. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem.
    Pachón-Ibáñez ME; Jiménez-Mejías ME; Pichardo C; Llanos AC; Pachón J
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Cui JC; Liu YN; Chen LA
    J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
    Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
    Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
    [No Abstract]   [Full Text] [Related]  

  • 11. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
    Peleg AY; Potoski BA; Rea R; Adams J; Sethi J; Capitano B; Husain S; Kwak EJ; Bhat SV; Paterson DL
    J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid development of Acinetobacter baumannii resistance to tigecycline.
    Reid GE; Grim SA; Aldeza CA; Janda WM; Clark NM
    Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
    Betts JW; Kelly SM; Haswell SJ
    Int J Antimicrob Agents; 2011 Nov; 38(5):421-5. PubMed ID: 21885260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii.
    Hawser SP; Hackel M; Person MB; Higgins PG; Seifert H; Dowzicky M
    Int J Antimicrob Agents; 2010 Sep; 36(3):289-90. PubMed ID: 20558046
    [No Abstract]   [Full Text] [Related]  

  • 15. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial.
    Halstead DC; Abid J; Dowzicky MJ
    J Infect; 2007 Jul; 55(1):49-57. PubMed ID: 17250897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY; Ng LS; Tan E; Huang G
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).
    Flamm RK; Castanheira M; Streit JM; Jones RN
    Diagn Microbiol Infect Dis; 2016 Jul; 85(3):352-355. PubMed ID: 27112832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.
    Wareham DW; Gordon NC; Casals JB; Bean DC
    J Antimicrob Chemother; 2009 May; 63(5):1075-6. PubMed ID: 19279048
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
    Ozbek B; Otük G
    Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.